Oura was founded in Finland in 2015, an early believer that the best health signal comes from your finger, not your wrist. Today it has sold more than 6 million rings and become one of the breakout companies in consumer health.
I recently had the opportunity to host Tom Hale, Oura CEO, at Icons. Tom stepped in as CEO in 2022, when the company had a beloved product but was still largely unknown.
What fascinated me most wasn’t the growth itself, but how clearly Tom thinks about turning a great product into a durable, mission-driven business.
Here are six insights from our conversation:
1. The opportunity is enormous and still barely tapped. Hundreds of millions wear a biometric device, but billions do not, and awareness still trails the biggest names in tech. When a category is this underpenetrated, the ceiling is very high.
2. A great product markets itself. When Tom joined Oura, the company pulled back hard on paid marketing and sales remained steady; organic word-of-mouth fueled record months of sales. When customers recommend the product to each other, growth stops being something you buy.
3. The shift that won was from wearables for fitness to wearables for health. Fitness use cases churn; health keeps people. Proactive features, like flagging illness before you feel it, build trust that compounds into a flywheel.
4. Mission and commercial discipline reinforce each other. A mission-driven health company attracts talent it could never otherwise recruit. But giving the product away is not impact; reaching millions of people is, and that requires a real business.
5. Software is the value, and subscription funds the vision. Moving from a hardware-upgrade cycle to a subscription reframed the app as the product, not an accessory. That recurring revenue funds the research that makes the subscription more valuable over time.
6. Scaling is a different game than building, and you have to want it. Tom’s advice: build an organization that runs without any one person, through delegation, strong culture, relentless recruiting, and just enough process. And be honest, because if scaling doesn’t genuinely interest you, hand it to someone who loves it.
Thank you, Tom, for such a generous and candid conversation. A rare look at how a beautifully designed product becomes one of the defining health companies of this era.

